Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Aug 4;140(5):407-409.
doi: 10.1182/blood.2022017071.

CLL and COVID-19: light at the end of the tunnel?

Lydia Scarfò  1 , Yair Herishanu  2
Affiliations
Editorial

CLL and COVID-19: light at the end of the tunnel?

Lydia Scarfò et al. Blood. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: L.S. was a member of advisory boards for AbbVie, AstraZeneca, BeiGene, and Janssen. Y.H. has received honoraria from Janssen, AbbVie, Roche, Astra-Zeneca and Medison Pharma.

Figures

None
COVID-19–related mortality in patients with CLL over time. The COVID-19–related mortality in patients with CLL during different waves of COVID-19 (initial studies on the left) is depicted. Initial studies (up to 35%, on the left) reported the highest mortality rate for COVID-19, whereas more recent retrospective series documented a much lower mortality rate (1%-23%, depending on the setting of data collection).
See this image and copyright information in PMC

Comment on

References

    1. Niemann CU, da Cunha-Bang C, Helleberg M, Ostrowski SR, Brieghel C. Patients with CLL have a lower risk of death from COVID-19 in the Omicron era. Blood. 2022;140(5):445-450. - PMC - PubMed
    1. Vijenthira A, Gong IY, Fox TA, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136(25):2881-2892. - PMC - PubMed
    1. Mato AR, Roeker LE, Lamanna N, et al. Outcomes of COVID-19 in patients with CLL: a multicenter international experience. Blood. 2020;136(10):1134-1143. - PMC - PubMed
    1. Scarfò L, Chatzikonstantinou T, Rigolin GM, et al. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. Leukemia. 2020;34(9):2354-2363. - PMC - PubMed
    1. Roeker LE, Eyre TA, Thompson MC, et al. COVID-19 in patients with CLL: improved survival outcomes and update on management strategies. Blood. 2021;138(18):1768-1773. - PMC - PubMed